FIA
INBX icon

FNY Investment Advisers’s Inhibrx INBX Stock Holding History

FNY Investment Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Hold
250
– – 0.01% 516
2026
Q1 		$16K Hold
250
– – 0.01% 494
2025
Q4 		$19K Hold
250
– – 0.01% 570
2025
Q3 		$8K Hold
250
– – ﹤0.01% 840
2025
Q2 		$3K Hold
250
– – ﹤0.01% 799
2025
Q1 		$3K Hold
250
– – ﹤0.01% 617
2024
Q4 		$3K Buy
250
+125
+100% +$1.9K ﹤0.01% 565
2024
Q3 		$1K Buy
+125
New +$1.76K ﹤0.01% 622

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CGIM
Cannon Global Investment Management Davie, Florida $35.4M AUM 47.4% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
PCM
Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FNY Investment Advisers's INBX Position: Q2 2026 in Review

FNY Investment Advisers held its Inhibrx (INBX) position steady in Q2 2026 at 250 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #516.

FNY Investment Advisers first reported a position in INBX in Q3 2024 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • FNY Investment Advisers held 250 shares of Inhibrx worth $23K as of Q2 2026.
  • FNY Investment Advisers left its Inhibrx share count unchanged in Q2 2026.
  • Inhibrx made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #516 holding.
  • FNY Investment Advisers first reported a position in Inhibrx in Q3 2024 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.